Erratum to "Association between generalized anxiety levels and pain in a community sample: Evidence for diagnostic specificity" [J. Anxiety Disord. 23(5) (2009) 684-693] (DOI:10.1016/j.janxdis.2009.02.007);Association between generalized anxiety levels and pain in a community sample: Evidence for diagnostic specificity

Journal of Anxiety Disorders

Volumn 23, Issue 5, 2009, Pages 684-693

  Beesdo, Katja ^a   Hoyer, Jürgen ^a   Jacobi, Frank ^a   Low, Nancy C P ^b   Höfler, Michael ^a   Wittchen, Hans Ulrich ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Epidemiology; Generalized anxiety disorder; Pain; Population based sample

Indexed keywords

ADULT; AGED; ANXIETY DISORDER; ARTICLE; COMMUNITY SAMPLE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DOSE RESPONSE; FEMALE; GENERALIZED ANXIETY DISORDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PAIN; PAIN THRESHOLD; PHYSICAL DISEASE; POPULATION BASED CASE CONTROL STUDY; SYMPTOM;

EID: 64249102515     PISSN: 08876185     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.janxdis.2009.09.001     Document Type: Erratum

References (83)

1. Allgulander C., Hartford J., Russell J., Ball S., Erickson J., Raskin J., et al. Pharmacotherapy of generalized anxiety disorder: Results of duloxetine treatment from a pooled analysis of three clinical trials. Current Medical Research and Opinion 23 6 (2007) 1245-1252
2. APA. Diagnostic and statistical manual of mental disorders. 4th Ed. (1994), American Psychiatric Press, Washington, DC
3. Asmundson G.J.G., Norton P.J., and Vlaeyen J.W.S. Fear-avoidance models of chronic pain: An overview. In: Asmundson G.J.G., Vlaeyen J.W.S., and Crombez G. (Eds). Understanding and treating fear of pain (2004), Oxford University Press, Oxford 3-24
4. Beekman A.T.F., Bremmer M.A., Deeg D.J., van Balkom A.J., Smit J.H., de Beurs E., et al. Anxiety disorders in later life: A report from the Longitudinal Aging Study Amsterdam. International Journal of Geriatric Psychiatry 13 (1998) 717-726
5. Beesdo K. Wie entstehen Generalisierte Ängste? Eine prospektiv-longitudinale, klinisch-epidemiologische Studie bei Jugendlichen und jungen Erwachsenen (The development of generalized anxiety. A prospective-longitudinal, clinical-epidemiologic study among adolescents and young adults) (2006), TUD Press, Dresden
6. Beesdo K., Gloster A.T., Jacobi F., and Wittchen H.U. Is pain associated with anxiety disorders? Results from a community study. Biological Psychiatry 61 Suppl. 8S (2007) 48S
7. Bellach B.-M., Ellert U., and Radoschewski M. Epidemiologie des Schmerzes-Ergebnisse des Bundes-Gesundheitssurveys 1998. Bundesgesundheitsbl-Gesundheitsforsch-Gesundheitsschutz 43 (2000) 424-431
8. Bijl R., de Graaf R., Ravelli A., Smit F., and Vollebergh W.A.M. Gender and age-specific first incidence of DSM-III-R psychiatric disorders in the general population. Social Psychiatry and Psychiatric Epidemiology 37 (2002) 372-379
9. Borkovec T.D., and Ruscio A.M. Psychotherapy for generalized anxiety disorder. Journal of Clinical Psychiatry 62 Suppl. 11 (2001) 37-42
10. Briley M. Clinical experience with dual action antidepressants in different chronic pain syndromes. Human Psychopharmacology 19 (2004) s21-s25
11. Bullinger M., and Kirchberger I. SF-36 Fragebogen zum Gesundheitszustand. Handanweisung (1998), Hogrefe, Göttingen
12. Bullinger M., Alonso J., Apolone G., Leplège A., Sullivan M., Wood-Dauphinee S., et al. Translating health status questionnaires and evaluating their quality. The IQOLA project approach. Journal of Clinical Epidemiology 51 11 (1998) 913-923
13. Butterworth P., and Crosier T. The validity of the SF-36 in an Australian National Household Survey: Demonstrating the applicability of the household income and labour dynamics in Australia (HILDA) survey to examination of health inequalities. BMC Public Health 4 1 (2004) 44
14. Carter R.M., Wittchen H.-U., Pfister H., and Kessler R.C. One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample. Depression and Anxiety 13 (2001) 78-88
15. Cohen S., and Rodriguez M.S. Pathways linking affective disturbances and physical disorders. Health Psychology 14 5 (1995) 374-380
16. Crofford L.J., Rowbotham M.C., Mease P.J., Russell I.J., Dworkin R.H., Corbin A.E., et al. Pregabalin for the treatment of fibromyalgia syndrome. Arthritis and Rheumatism 52 4 (2005) 1264-1273
17. Demyttenaere K., Bruffaerts R., Lee S., Posada-Villa J., Kovess V., Angermeyer M.C., et al. Mental disorders among persons with chronic back or neck pain: Results from the world mental health surveys. Pain 129 (2007) 332-342
18. Ellert U., and Bellach B.-M. Der SF-36 im Bundes-Gesundhetissurvey-Beschreibung einer aktuellen Normstichprobe. Gesundheitswesen 61 (1999) S184-S190
19. Elliott A.M., Smith B.H., Penny K.I., Smith W.C., and Chambers W.A. The epidemiology of chronic pain in the community. The Lancet 354 (1999) 1248-1252
20. Eriksen J., Jensen M.K., Sjogren P., Ekholm O., and Rasmussen N.K. Epidemiology of chronic non-malignant pain in Denmark. Pain 106 (2003) 221-228
21. Goodwin R.D., and Gorman J.M. Psychopharmacologic treatment of generalized anxiety disorder and the risk of major depression. American Journal of Psychiatry 159 (2002) 1935-1937
22. Grothe D.R., Scheckner B., and Albano D. Treatment of pain syndromes with venlafaxine. Pharmacotherapy 24 5 (2004) 621-629
23. Gureje O., Von Korff M., Kola L., Demyttenaere K., He Y., Posada-Villa J., et al. The relation between multiple pains and mental disorders: Results from the world mental health surveys. Pain 135 (2008) 82-91
24. Gutierrez M.A., Stimmel G.L., and Aiso J.Y. Venlafaxine: A 2003 update. Clinical Therapeutics 25 8 (2003) 2138-2154
25. Hettema J.M. The nosological relationship between generalized anxiety disorder and major depression. Depression and Anxiety 25 (2008) 300-316
26. Hiller W. Don't change a winning horse. Journal of Psychosomatic Research 60 (2006) 345-374
27. Hopman W.M., Towheed T., Anastassiades T., Tenenhouse A., Poliquin S., Berger C., et al. Canadian normative data for the SF-36 health survey. Canadian Medical Association Journal 163 3 (2000) 265-271
28. Hoyer J., Beesdo K., Becker E.S., and Wittchen H.-U. Epidemiologie und nosologischer Status der Generalisierten Angststörung (Epidemiology of generalized anxiety disorder). Zeitschrift für Klinische Psychologie und Psychotherapie 32 4 (2003) 267-275
29. Hoyer J., Beesdo K., Gloster A.T., Höfler M., Runge J., and Becker E.S. Worry exposure versus applied relaxation in the treatment of generalized anxiety disorder. Psychotherapy and Psychosomatics 78 (2009) 106-115
30. Jacobi F., Wittchen H.-U., Hölting C., Sommer S., Lieb R., Höfler M., et al. Estimating the prevalence of mental and somatic disorders in the community: Aims and methods of the German national health interview and examination survey. International Journal of Methods in Psychiatric Research 11 1 (2002) 1-18
31. Judd L.L., Kessler R.C., Paulus M.P., Zeller P.V., Wittchen H.-U., and Kunovac J.L. Comorbidity as a fundamental feature of generalized anxiety disorders: Results from the national comorbidity study (NCS). Acta Psychiatrica Scandinavica 98 Suppl. 393 (1998) 6-11
32. Kessler R.C. Evidence that generalized anxiety disorder is an independent disorder. In: Nutt D.J., Rickels K., and Stein D.J. (Eds). Generalized anxiety disorder: Symptomatology, pathogenesis and management. (2002), Martin Dunitz, London 3-10
33. Kessler R.C., Walters E.E., and Wittchen H.-U. Epidemiology of generalized anxiety disorder. In: Heimberg R.G., Turk C.L., and Mennin D.S. (Eds). Generalized anxiety disorder: Advances in research and practise (2004), Guilford, New York 446
34. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., and Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Archives of General Psychiatry 62 (2005) 593-602
35. Knäuper B., and Wittchen H.-U. Diagnosing major depression in the elderly: Evidence for response bias in standardized diagnostic interviews?. Journal of Psychiatric Research 28 2 (1994) 147-164
36. Kroenke K. Physical symptom disorder: A simpler diagnostic category for somatization-spectrum conditions. Journal of Psychosomatic Research 60 (2006) 335-339
37. Lachner G., Wittchen H.-U., Perkonigg A., Holly A., Schuster P., Wunderlich U., et al. Structure, content and reliability of the Munich composite international diagnostic interview (M-CIDI). Substance use sections. European Addiction Research 4 1-2 (1998) 28-41
38. Lawless J.F. Negative binomial and mixed Poisson regression. Canadian Journal of Statistics 15 3 (1987) 209-255
39. Mayou R., Kirmayer L.J., Simon G., Kroenke K., and Sharpe M. Somatoform disorders: Time for a new approach in DSM-V. American Journal of Psychiatry 162 5 (2005) 847-855
40. McBeth J., and Jones K. Epidemiology of chronic musculoskeletal pain. Bailliere's Best Practice and Research in Clinical Rheumatology 21 3 (2007) 403-425
41. McHorney C., Ware J.E., and Raczek A. The MOS 36-item short-form health survey (SF-36). II. Psychometric and clinical-tests of validity in measuring physical and mental-health constructs. Medical Care 31 3 (1993) 247-263
42. McWilliams L.A., Cox B.J., and Enns M.W. Mood and anxiety disorders associated with chronic pain: An examination in a nationally representative sample. Pain 106 (2003) 127-133
43. McWilliams L.A., Goodwin R.D., and Cox B.J. Depression and anxiety associated with three pain conditions: Results from a nationally representative sample. Pain 111 (2004) 77-83
44. Mennin D.S., Heimberg R.G., Fresco D.M., and Ritter M.R. Is generalized anxiety disorder an anxiety or mood disorder? Considering multiple factors as we ponder the fate of GAD. Depression and Anxiety 25 (2008) 289-299
45. Meoni P., Hackett D., and Lader M. Pooled analysis of venlafaxine XR efficacy on somatic and psychic symptoms of anxiety in patients with generalized anxiety disorder. Depression and Anxiety 19 (2004) 127-132
46. Mitte K. Meta-analysis of cognitive-behavioral treatments for generalized anxiety disorder: A comparison with pharmacotherapy. Psychological Bulletin 131 5 (2005) 785-795
47. Moffitt T.E., Harrington H., Caspi A., Kim-Cohen J., Goldberg D., Gregory A.M., et al. Depression and generalized anxiety disorder: Cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years. Archives of General Psychiatry 64 (2007) 651-660
48. Montgomery S.A., Tobias K., Zornberg G.L., Kasper S., and Pande A.C. Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: A 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine. Journal of Clinical Psychiatry 67 (2006) 771-782
49. Moore J.E., VonKorff M., Cherkin D., Saunders K., and Lorig K. A randomized trial of a cognitive-behavioral program for enhancing back pain self care in a primary care setting. Pain 88 (2000) 145-153
50. Newman M.G., Zuellig A.R., Kachin K.E., Constantino M.J., Przeworski A., Erickson T., et al. Preliminary reliability and validity of the generalized anxiety disorder questionnaire-IV: A revised self-report diagnostic measure of generalized anxiety disorder. Behavior Therapy 33 2 (2002) 215-233
51. Norton P.J., and Asmundson G.J.G. Anxiety sensitivity, fear, and avoidance behavior in headache pain. Pain 111 (2004) 218-223
52. Olfson M., and Gameroff M.J. Generalized anxiety disorder, somatic pain and health care costs. General Hospital Psychiatry 29 (2007) 310-316
53. Ormel J., Petukhova M., Chatterji S., Aguilar-Gaxiola S., Alonso J., Angermeyer M.C., et al. Disability and treatment of specific mental and physical disorders across the world. British Journal of Psychiatry 192 (2008) 368-375
54. Price D.D. Central neural mechanisms that interrelate sensory and affective dimensions of pain. Molecular Interventions 2 6 (2002) 392-403
55. Reed V., Gander F., Pfister H., Steiger A., Sonntag H., Trenkwalder C., et al. To what degree the composite international diagnostic interview (CIDI) correctly identify DSM-IV disorders? Testing validity issues in a clinical sample. International Journal of Methods in Psychiatric Research 7 3 (1998) 142-155
56. Rief W., and Broadbent E. Explaining medically unexplained symptoms-models and mechanisms. Clinical Psychology Review 27 (2007) 821-841
57. Rubio-Stipec M., Canino G., Robins L.N., Wittchen H.U., Sartorius N., and Torres de Miranda C. The somatization schedule of the composite international diagnostic interview: The use of the probe flow chart in 17 different countries. International Journal of Methods in Psychiatric Research 3 (1993) 129-136
58. Ruscio A.M., Lane M., Roy-Byrne P., Stang P.E., Stein D.J., Wittchen H.-U., et al. Should excessive worry be required for a diagnosis of generalized anxiety disorder? Results from the US national comorbidity survey replication. Psychological Medicine 35 12 (2005) 1761-1772
59. Ruscio A.M., Chiu W.T., Roy-Byrne P., Stang P.E., Stein D.J., Wittchen H.-U., et al. Broadening the definition of generalized anxiety disorder: Effects on prevalence and associations with other disorders in the national comorbidity survey replication. Journal of Anxiety Disorders 21 (2007) 662-676
60. Sareen J., Jacobi F., Cox B.J., Belik S.-L., Clara I., and Stein M.B. Disability and poor quality of life associated with comorbid anxiety disorders and physical conditions. Archives of Internal Medicine 166 (2006) 2109-2116
61. Sharpe M., Mayou R., and Walker J. Bodily symptoms: New approaches to classification. Journal of Psychosomatic Research 60 (2006) 353-356
62. Smith B.H., Elliott A.M., Hannaford P.C., Chambers W.A., and Smith W.C. Factors related to the onset and persistence of chronic back pain in the community-results from a general population follow-up study. Spine 29 9 (2004) 1032-1040
63. Smith B.H., Macfarlane G.J., and Torrance N. Epidemiology of chronic pain, from the laboratory to the bus stop: Time to add understanding of biological mechanisms to the study of risk factors in population-based research?. Pain 127 1-2 (2007) 5-10
64. StataCorp. Stata statistical software: Release 10.0 (2007), Stata Corporation, College Station
65. Sullivan M.D. DSM-IV pain disorder: A case against the diagnosis. International Review of Psychiatry 12 (2000) 91-98
66. Sullivan M., and Karlsson J. The Swedish SF-36 health survey. III. Evaluation of criterion-based validity: Results from normative population. Journal of Clinical Epidemiology 51 11 (1998) 1105-1113
67. Sykes R. Somatoform disorders in DSM-IV: Mental or physical disorders?. Journal of Psychosomatic Research 60 (2006) 341-344
68. Torrance N., Smith B., Bennett M., and Lee A. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. Journal of Pain 7 4 (2006) 281-289
69. Turner-Stokes L., Erkeller-Yuksel F., Miles A., Pincus T., Shipley M., and Pearce S. Outpatient cognitive behavioral pain management programs: A randomized comparison of a group-based multidisciplinary versus an individual therapy model. Archives of Physical Medicine 84 6 (2003) 781-788
70. Von Korff M., Balderson B.H.K., Saunders K., Miglioretti D.L., Lin E.H.B., Berry S., et al. A trial of an activating intervention for chronic back pain in primary care and physical therapy settings. Pain 113 (2005) 323-330
71. Von Korff M., Crane P., Lane M., Miglioretti D.L., Simon G., Saunders K., et al. Chronic spinal pain and physical-mental comorbidity in the United States: Results from the national comorbidity survey replication. Pain 113 (2005) 331-339
72. Ware J.E., and Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care 30 (1992) 473-483
73. Ware J.E., Kosinski M., Gandek B., Aaronson N., Apolone G., Bech P., et al. The factor structure of the SF-36 health survey in 10 countries: Results from the IQOLA project. Journal of Clinical Epidemiology 51 11 (1998) 1159-1165
74. Watson D., O'Hara M.W., and Scott S. Hierarchical structures of affect and psychopathology and their implications for the classification of emotional disorders. Depression and Anxiety 25 (2008) 282-288
75. WHO. The ICD-10 classification of mental and behavioural disorders: Diagnostic criteria for research (1993), World Health Organization, Geneva, Switzerland
76. Wittchen H.-U. Reliability and validity studies of the WHO-composite international diagnostic interview (CIDI): A critical review. Journal of Psychiatric Research 28 1 (1994) 57-84
77. Wittchen H.-U., and Boyer P. Screening for anxiety disorders. Sensitivity and specificity of the anxiety screening questionnaire (ASQ-15). British Journal of Psychiatry 173 Suppl. 34 (1998) 10-17
78. Wittchen H.-U., and Hoyer J. Generalized anxiety disorder: Nature and course. Journal of Clinical Psychiatry 62 Suppl. 11 (2001) 15-19
79. Wittchen H.-U., and Pfister H. DIA-X-Interviews: Manual für Screening-Verfahren und Interview; Interviewheft Längsschnittuntersuchung (DIA-X-Lifetime); Ergänzungsheft (DIA-X-Lifetime); Interviewheft Querschnittuntersuchung (DIA-X-12 Monate); Ergänzungsheft (DIA-X-12Monate); PC-Programm zur Durchführung des Interviews (Längs- und Querschnittuntersuchung); Auswertungsprogramm (1997), Swets & Zeitlinger, Frankfurt
80. Wittchen H.-U., Essau C.A., Rief W., and Fichter M.M. Assessment of somatoform disorders and comorbidity pattern with the CIDI-findings in psychosomatic inpatients. International Journal of Methods in Psychiatric Research 3 2 (1993) 87-99
81. Wittchen H.-U., Lachner G., Wunderlich U., and Pfister H. Test-retest reliability of the computerized DSM-IV version of the Munich-composite international diagnostic interview (M-CIDI). Social Psychiatry and Psychiatric Epidemiology 33 11 (1998) 568-578
82. Wittchen H.-U., Beesdo K., and Kessler R.C. The impact of generalized anxiety disorder. In: Nutt D.J., Rickels K., and Stein D.J. (Eds). Generalized anxiety disorder: Symptomatology, pathogenesis and management (2002), Martin Dunitz, London 11-26
83. Wittchen H.-U., Kessler R.C., Beesdo K., Krause P., Höfler M., and Hoyer J. Generalized anxiety and depression in primary care: Prevalence, recognition and management. Journal of Clinical Psychiatry 63 8 (2002) 24-34